✦ LIBER ✦

Pathophysiology and biochemistry of dyskinesia: clues for the development of non-dopaminergic treatments

✍ Scribed by Peter Jenner

Book ID: 105745444
Publisher: Springer
Year: 2000
Tongue: English
Weight: 47 KB
Volume: 247
Category: Article
ISSN: 0340-5354
DOI: 10.1007/pl00007760

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathophysiology and biochemistry of dysk

Pathophysiology and biochemistry of dyskinesia: clues for the development of non-dopaminergic treatments

✍ Peter Jenner 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 47 KB

Development of dopaminergic drugs for th

Development of dopaminergic drugs for the chronic treatment of congestive heart failure

✍ Casagrande, C. ;Merlo, L. ;Regina, A. La 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 694 KB

Vitamin E attenuates the development of

Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia

✍ W. F. Gattaz; A. Emrich; S. Behrens 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 311 KB

Development of Radioimmunotherapy for th

Development of Radioimmunotherapy for the Treatment of Non-Hodgkin’s Lymphoma

✍ P. Multani 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 148 KB

The pathophysiology of bronchial asthma

The pathophysiology of bronchial asthma and targets for its drug treatment

✍ Stephen T. Holgate 📂 Article 📅 1986 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 638 KB

Age of Parkinson's disease onset as a pr

Age of Parkinson's disease onset as a predictor for the development of dyskinesia

✍ Stephen Ku; Graham A. Glass 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

## Abstract The risk of developing levodopa‐associated dyskinesia is known to vary inversely with the age of Parkinson's disease onset. This study quantifies dyskinesia risks for different Parkinson's onset ages in a patient population treated at the Parkinson's Disease Research, Education, and Cli